L-741,626

From WikiMD's WELLNESSPEDIA

L-741,626.svg

L-741,626 is a chemical compound that acts as a selective antagonist for the dopamine receptor D2. It is primarily used in scientific research to study the role of D2 receptors in various physiological and pathological processes.

Chemical Properties[edit]

L-741,626 has the following chemical properties:

  • IUPAC name: 3-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl-1H-indole
  • Molecular formula: C20H21ClN2O
  • Molar mass: 340.85 g/mol

Pharmacology[edit]

L-741,626 is known for its high affinity and selectivity for the dopamine receptor D2, which is a subtype of the dopamine receptor family. By binding to these receptors, L-741,626 inhibits the action of dopamine, a neurotransmitter involved in various functions including motor control, motivation, and reward.

Research Applications[edit]

L-741,626 is widely used in neuroscience research to investigate the role of D2 receptors in the brain. It has been utilized in studies related to schizophrenia, Parkinson's disease, and drug addiction. By blocking D2 receptors, researchers can better understand the contribution of these receptors to the symptoms and progression of these conditions.

Mechanism of Action[edit]

As a D2 receptor antagonist, L-741,626 binds to the receptor and prevents dopamine from activating it. This blockade can help elucidate the downstream effects of D2 receptor inhibition, including changes in neurotransmitter release, neuronal firing patterns, and behavioral outcomes.

Safety and Handling[edit]

L-741,626 should be handled with care in a laboratory setting. Appropriate safety measures, including the use of personal protective equipment (PPE) and proper ventilation, should be followed to avoid exposure.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.